A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
Blood Cancer Journal, Published online: 22 May 2023; doi:10.1038/s41408-023-00854-2A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2023 Category: Hematology Authors: A. Vera de Jonge Erik van Werkhoven Avinash G. Dinmohamed Marcel Nijland Aeilko H. Zwinderman Patrick M. Bossuyt Martine S. Veldhuis Emma G. G. M. Rutten Rogier Mous Joost S. P. Vermaat Yorick Sandberg Eva de Jongh Yavuz M. Bilgin Rinske Boersma Harry Koe Source Type: research
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma
Blood Cancer Journal, Published online: 22 May 2023; doi:10.1038/s41408-023-00851-5Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2023 Category: Hematology Authors: Linda B. Baughn Erik Jessen Neeraj Sharma Hongwei Tang James B. Smadbeck Mark D. Long Kathryn Pearce Matthew Smith Surendra Dasari Zohar Sachs Michael A. Linden Joselle Cook A. Keith Stewart Marta Chesi Amit Mitra P. Leif Bergsagel Brian Van Ness Shaji K. Source Type: research
High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma
Blood Cancer Journal, Published online: 22 May 2023; doi:10.1038/s41408-023-00855-1High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2023 Category: Hematology Authors: Xinhe Shan Qi Long Alfred L. Garfall Sandra P. Susanibar-Adaniya Source Type: research
Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies
Blood Cancer Journal, Published online: 19 May 2023; doi:10.1038/s41408-023-00849-zCardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 19, 2023 Category: Hematology Authors: Jean El-Cheikh Nour Moukalled Florent Malard Ali Bazarbachi Mohamad Mohty Source Type: research
Global burden of hematologic malignancies and evolution patterns over the past 30 years
Blood Cancer Journal, Published online: 17 May 2023; doi:10.1038/s41408-023-00853-3Global burden of hematologic malignancies and evolution patterns over the past 30 years (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 17, 2023 Category: Hematology Authors: Nan Zhang Jinxian Wu Qian Wang Yuxing Liang Xinqi Li Guopeng Chen Linlu Ma Xiaoyan Liu Fuling Zhou Source Type: research
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era
Blood Cancer Journal, Published online: 17 May 2023; doi:10.1038/s41408-023-00847-1Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 17, 2023 Category: Hematology Authors: Cristina Correia Matthew J. Maurer Samantha J. McDonough Paula A. Schneider Paige E. Ross Anne J. Novak Andrew L. Feldman James R. Cerhan Susan L. Slager Thomas E. Witzig Bruce W. Eckloff Hu Li Grzegorz S. Nowakowski Scott H. Kaufmann Source Type: research
Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics
Blood Cancer Journal, Published online: 17 May 2023; doi:10.1038/s41408-023-00857-zCorrection: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 17, 2023 Category: Hematology Authors: Bing Z. Carter Po Yee Mak Wenjing Tao Edward Ayoub Lauren B. Ostermann Xuelin Huang Sanam Loghavi Steffen Boettcher Yuki Nishida Vivian Ruvolo Paul E. Hughes Phuong K. Morrow Torsten Haferlach Steven Kornblau Muharrem Muftuoglu Michael Andreeff Source Type: research
Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development
Blood Cancer Journal, Published online: 16 May 2023; doi:10.1038/s41408-023-00815-9Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 16, 2023 Category: Hematology Authors: K. Forde K. Cocks J. R. Wells I. McMillan C. Kyriakou Source Type: research
Conditional survival in multiple myeloma and impact of prognostic factors over time
Blood Cancer Journal, Published online: 15 May 2023; doi:10.1038/s41408-023-00852-4Conditional survival in multiple myeloma and impact of prognostic factors over time (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 15, 2023 Category: Hematology Authors: Nadine H. Abdallah Alexandra N. Smith Susan Geyer Moritz Binder Patricia T. Greipp Prashant Kapoor Angela Dispenzieri Morie A. Gertz Linda B. Baughn Martha Q. Lacy Suzanne R. Hayman Francis K. Buadi David Dingli Yi L. Hwa Yi Lin Taxiarchis Kourelis Rahma Source Type: research
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group
Blood Cancer Journal, Published online: 12 May 2023; doi:10.1038/s41408-023-00835-5Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 12, 2023 Category: Hematology Authors: Claudia Sargas Rosa Ayala Mar ía J. Larráyoz Mar ía C. Chillón Eduardo Rodriguez-Arboli Cristina Bilbao Esther Prados de la Torre David Mart ínez-Cuadrón Rebeca Rodr íguez-Veiga Blanca Boluda Cristina Gil Teresa Bernal Juan Bergua Lorenzo Algarra M Source Type: research
Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study
Blood Cancer Journal, Published online: 10 May 2023; doi:10.1038/s41408-023-00843-5Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 10, 2023 Category: Hematology Authors: Hira Mian Tanya M. Wildes Ravi Vij Matthew J. Pianko Ajay Major Mark A. Fiala Source Type: research
Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study
Blood Cancer Journal, Published online: 10 May 2023; doi:10.1038/s41408-023-00845-3Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 10, 2023 Category: Hematology Authors: Yuan Yang Zengwei Tang Yuzhou Huang Qinglin Hu Shuqing Wang Jiang Ji Yali Du Chen Yang Miao Chen Shimin Hu Bing Han Source Type: research
DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation
Blood Cancer Journal, Published online: 10 May 2023; doi:10.1038/s41408-023-00846-2DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 10, 2023 Category: Hematology Authors: Benjamin Rolles Robert Meyer Matthias Begemann Miriam Elbracht Edgar Jost Matthias Stelljes Ingo Kurth Tim H. Br ümmendorf Gerda Silling Source Type: research
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months
Blood Cancer Journal, Published online: 10 May 2023; doi:10.1038/s41408-023-00848-0CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 10, 2023 Category: Hematology Authors: Zhenzhen Yao Bin Gu Jia Chen Yang Xu Feng Chen Shengli Xue Huiying Qiu Xiaowen Tang Yue Han Suning Chen Aining Sun Lei Yu Yanming Zhang Depei Wu Ying Wang Source Type: research
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study
Blood Cancer Journal, Published online: 09 May 2023; doi:10.1038/s41408-023-00797-8Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 9, 2023 Category: Hematology Authors: Thomas Martin Meletios-Athanasios Dimopoulos Joseph Mikhael Kwee Yong Marcelo Capra Thierry Facon Roman Hajek Ivan Špička Ross Baker Kihyun Kim Gracia Martinez Chang-Ki Min Ludek Pour Xavier Leleu Albert Oriol Youngil Koh Kenshi Suzuki France Casca Sand Source Type: research
